EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanistic inhibition of herpes simplex virus-1 UL21 immune-evasion function by natural-product scaffolds: A multi-tier docking, dynamics, and energetic profiling approach

Muhammad Suleman, Imtiaz Ali, Abrar Mohammad Sayaf, Fakhrul Hassan, Usama Ilahi, Mohammed Alissa iD, Sergio Crovella iD, Abdullah A Shaito iD, Hadi M Yassine

PLOS One · 2026

DOI: 10.1371/journal.pone.0355499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Muhammad Suleman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Center (BRC), QU Health, Qatar University, Doha, Qatar. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Biological Products, Antiviral Agents, Viral Proteins. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar Research, Development, and Innovation (QRDI) Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alpha-herpesviruses, particularly herpes simplex virus type 1 (HSV-1), establish lifelong latency and employ multiple strategies to evade host immunity, thereby sustaining infection. A key mediator of this immune evasion is the viral tegument protein, unique long 21 (UL21), which disrupts the host cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) signaling pathway and suppresses antiviral type-I interferon responses, facilitating viral replication. Despite its important role in HSV-1 pathogenesis, UL21 remains an underexplored therapeutic target. This study aimed to identify natural-product scaffolds capable of targeting the UL21 N-terminal domain and potentially interfering with UL21-mediated immune evasion. Using comprehensive virtual screening of East and South African natural-product libraries, we employed a multi-tier computational workflow comprising molecular docking, molecular dynamics (MD) simulations, and binding free-energy calculations. Four compounds, Saundersioside C, kaempferol 3,7,4′-tri-O-β-glucoside, soyasaponin II, and OSW‑1, emerged as promising UL21-binding candidates with favorable docking scores and stable interaction profiles. Docking scores for saundersioside C, kaempferol 3,7,4′-tri-O-β-glucoside, soyasaponin II, and OSW-1 were −9.05, −8.94 kcal/mol, −7.45 kcal/mol, and −7.30 kcal/mol, respectively. Molecular dynamics (MD) trajectory analyses demonstrated stable conformational behavior as indicated by consistent root mean square deviation (RMSD), limited structural fluctuations, and persistent structural compactness. Total binding free-energy calculations further identified kaempferol 3,7,4′-tri-O-β-glucoside (−40.9 kcal/mol MM/GBSA; −33.9 kcal/mol MM/PBSA) as the compound with the most favorable predicted binding affinity toward UL21. Collectively, these findings identify natural-product scaffolds with high potential to modulate UL21-mediated immune suppression, with kaempferol 3,7,4′-tri-O-β-glucoside emerging as the most promising candidate. The findings provide a foundation for experimental validation and future antiviral drug development targeting HSV-1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 1, HumanBiological ProductsAntiviral AgentsViral ProteinsMolecular Docking SimulationMolecular Dynamics SimulationHumans

Substanzen

Biological ProductsAntiviral AgentsViral Proteins

Autor:innen und Institutionen

  • Biomedical Research Center (BRC), QU Health, Qatar University, Doha, Qatar.
  • Center for Biotechnology and Microbiology, University of Swat, Swat, Pakistan.
  • School of Chemical Sciences, Universiti Sains Malaysia, Gelugor, Penang, Malaysia.
  • Department of Medical Laboratory Technology, Faculty of Rehabilitation and Allied Health Sciences, Riphah International University, Islamabad, Pakistan.
  • Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
  • Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.

ORCID-Profile: Mohammed Alissa, Sergio Crovella, Abdullah A Shaito

Förderung

  • Qatar Research, Development, and Innovation (QRDI) Council

Zitieren

APA

Suleman, M., Ali, I., Sayaf, A. M., Hassan, F., Ilahi, U., Alissa, M., Crovella, S., Shaito, A. A., & Yassine, H. M. (2026). Mechanistic inhibition of herpes simplex virus-1 UL21 immune-evasion function by natural-product scaffolds: A multi-tier docking, dynamics, and energetic profiling approach. PLOS One. https://doi.org/10.1371/journal.pone.0355499

Vancouver

Suleman M, Ali I, Sayaf AM, Hassan F, Ilahi U, Alissa M, et al. Mechanistic inhibition of herpes simplex virus-1 UL21 immune-evasion function by natural-product scaffolds: A multi-tier docking, dynamics, and energetic profiling approach. PLOS One. 2026. doi:10.1371/journal.pone.0355499

BibTeX
@article{Suleman2026,
  author = {Suleman, Muhammad and Ali, Imtiaz and Sayaf, Abrar Mohammad and Hassan, Fakhrul and Ilahi, Usama and Alissa, Mohammed and Crovella, Sergio and Shaito, Abdullah A and Yassine, Hadi M},
  title = {Mechanistic inhibition of herpes simplex virus-1 UL21 immune-evasion function by natural-product scaffolds: A multi-tier docking, dynamics, and energetic profiling approach},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0355499}
}
Kostenlos starten →